European Radiology

, Volume 21, Issue 8, pp 1594–1599 | Cite as

Prevalence of enlarged mediastinal lymph nodes in heavy smokers—a comparative study

  • Johannes KirchnerEmail author
  • Esther Maria Kirchner
  • Jan Peter Goltz
  • Vivian-Wilma Lorenz
  • Ralph Kickuth



To evaluate the frequency of enlarged hilar or mediastinal lymph nodes in heavy smokers (more than 10 pack years) compared with non- smokers.

Material and methods

In a prospective study the CT findings of 88 consecutive patients (44 heavy smokers, 44 non- smokers) were analysed. Exclusion criteria were history of thoracic malignancy, sarcoidosis, occupational dust exposure or clinical evidence of pneumonia. Prevalence, size and site of enlarged lymph nodes were assessed by multidetector computed tomography (MDCT) and correlated with the cigarette consumption and the CT- findings of bronchitis and emphysema.


Twenty-three of the 44 heavy smokers (52%) showed enlarged mediastinal lymph nodes. Non- smokers showed enlarged lymph nodes in 9% (4/44). The most common site of enlarged lymph nodes was the regional station 7 according to the ATS mapping (subcarinal). The difference between the frequency of enlarged lymph nodes in heavy smokers and non- smokers was significant (chi- square 19.3, p < 0.0001). Airway wall thickening and emphysema were often associated with an increased number of enlarged nodes.


The present study demonstrates that enlarged mediastinal lymph nodes may occur in a rather high percentage of heavy smokers, especially in those with a MDCT finding of severe bronchitis.


Tobacco MDCT Lymph node enlargement Comparative study 


  1. 1.
    Hartman TE, Tazelaar HD, Swensen SJ, Müller NL (1997) Cigarette smoking: CT and pathologic findings of associated pulmonary diseases. Radiographics 17:377–90PubMedGoogle Scholar
  2. 2.
    Heyneman LE, Ward S, Lynch DA, Remy-Jardin M, Johkoh T, Müller NL (1999) Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol 173:1617–22PubMedGoogle Scholar
  3. 3.
    Kanne JP, Bilawich AM, Lee CH, Im JG, Müller NL (2007) Smoking-related emphysema and interstitial lung diseases. J Thorac Imaging 22:286–91PubMedCrossRefGoogle Scholar
  4. 4.
    Ryu JH, Colby TV, Hartman TE, Vassallo R (2001) Smoking-related interstitial lung diseases: a concise review. Eur Respir J 17:122–32PubMedCrossRefGoogle Scholar
  5. 5.
    Wells AU, Nicholson AG, Hansell DM (2007) Challenges in pulmonary fibrosis. 4: smoking-induced diffuse interstitial lung diseases. Thorax 62:904–10PubMedCrossRefGoogle Scholar
  6. 6.
    Bates DV (1968) Chronic bronchitis and emphysema. N Engl J Med 278:546–51PubMedCrossRefGoogle Scholar
  7. 7.
    Fraser RG, Fraser RS, Renner JW, Bernard C, Fitzgerald PJ (1976) The roentgenologic diagnosis of chronic bronchitis: a reassessment with emphasis on parahilar bronchi seen end-on. Radiology 120:1–9PubMedGoogle Scholar
  8. 8.
    Gückel C, Hansell DM (1998) Imaging the 'dirty lung'–has high resolution computed tomography cleared the smoke? Clin Radiol 53:717–22PubMedCrossRefGoogle Scholar
  9. 9.
    Reid L, Simon G (1959) III. Pathological findings and radiological changes in chronic bronchitis and emphysema. Br J Radiol 32:291–305PubMedCrossRefGoogle Scholar
  10. 10.
    Remy-Jardin M, Remy J, Gosselin B, Becette V, Edme JL (1993) Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 186:643–51PubMedGoogle Scholar
  11. 11.
    Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB (1985) Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 144:261–5PubMedGoogle Scholar
  12. 12.
    American Thoracic Society. Medical section of the American Lung Association (1983) Clinical staging of primary lung cancer. Am Rev Respir Dis 127:659–64Google Scholar
  13. 13.
    Awadh N, Müller NL, Park CS, Abboud RT, FitzGerald JM (1998) Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax 53:248–53PubMedCrossRefGoogle Scholar
  14. 14.
    Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697–722PubMedCrossRefGoogle Scholar
  15. 15.
    Faul F, Erdfelder E, Buchner A, Lang AG (2009) Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods 41:1149–60PubMedCrossRefGoogle Scholar
  16. 16.
    Hunt BM, Vallières E, Buduhan G, Aye R, Louie B (2009) Sarcoidosis as a benign cause of lymphadenopathy in cancer patients. Am J Surg 197:629–32PubMedCrossRefGoogle Scholar
  17. 17.
    Ardekani MS, Issa M, Green L (2006) Diagnostic and economic impact of heart failure induced mediastinal lymphadenopathy. Int J Cardiol 109:137–8PubMedCrossRefGoogle Scholar
  18. 18.
    Kirchner J, Kirchner EM, Goltz JP, Obermann A, Kickuth R (2010) Enlarged hilar and mediastinal lymph nodes in chronic obstructive pulmonary disease. J Med Imaging Radiat Oncol 54:333–8PubMedCrossRefGoogle Scholar
  19. 19.
    Baldwin DR, Lambert L, Pantin CF, Prowse K, Cole RB (1996) Silicosis presenting as bilateral hilar lymphadenopathy. Thorax 51:1165–7PubMedCrossRefGoogle Scholar
  20. 20.
    de Langen AJ, Raijmakers P, Riphagen I, Paul MA, Hoekstra OS (2006) The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 29:26–9PubMedCrossRefGoogle Scholar
  21. 21.
    Quint LE, Francis IR (1999) Radiologic staging of lung cancer. J Thorac Imaging 14:235–46PubMedCrossRefGoogle Scholar
  22. 22.
    McLoud TC, Bourgouin PM, Greenberg RW (1992) Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 182:319–23PubMedGoogle Scholar
  23. 23.
    Arita T, Matsumoto T, Kuramitsu T, Kawamura M, Matsunaga N, Sugi K, Esato K (1996) Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen. Chest 110:1004–8PubMedCrossRefGoogle Scholar
  24. 24.
    Groth SS, Whitson BA, Maddaus MA (2008) Radiographic staging of mediastinal lymph nodes in non-small cell lung cancer patients. Thorac Surg Clin 18:349–61PubMedCrossRefGoogle Scholar
  25. 25.
    Kramer H, Groen HJ (2003) Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer. Ann Surg 238:180–8PubMedGoogle Scholar
  26. 26.
    Libshitz HI, McKenna RJ (1984) Mediastinal lymph node size in lung cancer. Am J Roentgenol 143:715–8Google Scholar
  27. 27.
    Ozawa Y, Hara M, Sakurai K, Nakagawa M, Tamaki T, Nishio M, Shibamoto Y (2010) Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Acta Radiol 51:150–5PubMedCrossRefGoogle Scholar
  28. 28.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F (2009) Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg 36:440–5PubMedCrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2011

Authors and Affiliations

  • Johannes Kirchner
    • 1
    Email author
  • Esther Maria Kirchner
    • 2
  • Jan Peter Goltz
    • 3
  • Vivian-Wilma Lorenz
    • 1
  • Ralph Kickuth
    • 3
  1. 1.Department of Diagnostic and Interventional RadiologyAllgemeines Krankenhaus HagenHagenGermany
  2. 2.Clinic for MedicineStädtisches Klinikum WedauDuisburgGermany
  3. 3.Department of RadiologyUniversity Hospital of WuerzburgWuerzburgGermany

Personalised recommendations